ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,280Medicare Part D Prescriptions Filled, Including Refills

Rank: 53 out of 1499

$788K Total Retail Price of All Prescriptions

Rank: 126 out of 1499

550 Patients Receiving at Least One Drug in Part D
97%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 550 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

28% of this provider’s 550 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 19,675 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
SIMVASTATIN 1,003 986 1 3
HYDROCODONE-ACETAMINOPHEN 901 882 S3 2 4
LISINOPRIL 863 851 3 1
WARFARIN SODIUM 793 793 4 12
LEVOTHYROXINE SODIUM 784 776 5 2
LOVASTATIN 635 626 6 19
AMLODIPINE BESYLATE 566 548 7 6
FUROSEMIDE 561 549 8 7
POTASSIUM CHLORIDE 424 424 9 11
OMEPRAZOLE 408 408 10 5
CITALOPRAM HBR 392 382 11 14
PRAVASTATIN SODIUM 381 378 12 18
METOPROLOL TARTRATE 377 364 13 10
MIRTAZAPINE 350 347 14 50
METFORMIN HCL 314 300 15 8
CARVEDILOL 304 304 16 22
DONEPEZIL HCL 255 250 17 35
RANITIDINE HCL 248 239 18 15
HYDROCHLOROTHIAZIDE 244 244 19 9
SERTRALINE HCL 236 224 20 24
ALLOPURINOL 195 183 21 36
LOSARTAN POTASSIUM 194 192 22 26
ATENOLOL 188 188 23 21
KLOR-CON M20 188 188 23 97
TRAMADOL HCL 186 133 25 16
ATORVASTATIN CALCIUM 185 168 26 17
JANTOVEN 172 172 27 195
NAMENDA 171 171 28 47
TRAZODONE HCL 160 147 29 32
FLUTICASONE PROPIONATE 155 151 30 31
PREDNISONE 152 152 31 42
ZOLPIDEM TARTRATE 150 150 32 23
TAMSULOSIN HCL 148 148 33 29
GABAPENTIN 127 121 34 13
HYDRALAZINE HCL 121 121 35 118
ISOSORBIDE MONONITRATE ER 120 120 36 51
LANTUS 111 103 37 46
BUMETANIDE 111 111 37 167
QUETIAPINE FUMARATE 109 108 39 72
CLOPIDOGREL 109 109 39 39
GLIMEPIRIDE 105 105 41 38
FLUOXETINE HCL 101 101 42 43
SPIRIVA 96 84 43 44
PAROXETINE HCL 96 96 43 59
NORTRIPTYLINE HCL 92 92 45 203
FAMOTIDINE 91 91 46 86
NEXIUM 91 85 46 28
PLAVIX 90 90 48 54
SPIRONOLACTONE 89 77 49 61
GLIPIZIDE 85 85 50 64
ALENDRONATE SODIUM 83 83 51 33
CARBIDOPA-LEVODOPA 82 82 52 92
VERAPAMIL ER 81 81 53 117
DIVALPROEX SODIUM 80 78 54 100
PROPRANOLOL HCL 78 62 55 115
ESCITALOPRAM OXALATE 78 72 55 76
CRESTOR 77 77 57 34
RISPERIDONE 76 75 58 74
METOPROLOL SUCCINATE 74 74 59 20
AZITHROMYCIN 72 70 60 45
NOVOLOG MIX 70-30 71 57 61 288
NOVOLOG 71 60 61 110
CIPROFLOXACIN HCL 71 69 61 65
OXYCODONE-ACETAMINOPHEN 70 69 S2 64 80
PROAIR HFA 67 61 65 30
ZETIA 65 65 66 91
NOVOLIN 70-30 65 45 66 204
AMLODIPINE BESYLATE-BENAZEPRIL 65 65 66 109
DOXYCYCLINE HYCLATE 64 64 69 106
ADVAIR DISKUS 63 58 70 37
DILTIAZEM 24HR CD 62 62 71 82
ALBUTEROL SULFATE 62 60 71 152
LEVOTHROID 61 61 73 233
HALOPERIDOL 60 60 74 172
EXELON 59 59 75 166
FELODIPINE ER 59 59 75 197
DILTIAZEM ER 59 59 75 124
PHENYTOIN SODIUM EXTENDED 58 55 78 137
DIGOXIN 56 56 79 56
SINGULAIR 52 52 80 67
MORPHINE SULFATE ER 51 51 S2 81 85
LIPITOR 51 46 81 107
JANUVIA 51 42 81 84
LEVOFLOXACIN 51 51 81 101
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 21, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.